TCO-PEG4-NHS Ester
TCO-PEG4-NHS Ester Basic information
- Product Name:
- TCO-PEG4-NHS Ester
- Synonyms:
-
- TCO-PEG4-NHS Ester,Trans-Cyclooctene-PEG4-NHS ester
- TCO4-PEG4-NHS
- 5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1-(4E)-4-cycloocten-1-yl 17-(2,5-dioxo-1-pyrrolidinyl) ester
- TCO-PEG4-NHS(contains 6% Dichloromethane at maximum)
- (E)-2,5-Dioxopyrrolidin-1-yl 1-(cyclooct-4-en-1-yloxy)-1-oxo-5,8,11,14-tetraoxa-2-azaheptadecan-17-oate
- (E)-TCO-PEG4-NHS ester
- TCO-PEG4-NHS Ester (CCT-A137)
- CAS:
- 1621096-79-4
- MF:
- C24H38N2O10
- MW:
- 514.57
- Product Categories:
-
- SiChem
- Mol File:
- 1621096-79-4.mol
TCO-PEG4-NHS Ester Chemical Properties
- Density
- 1.23±0.1 g/cm3(Predicted)
- storage temp.
- Storage temp. -20°C
- solubility
- DMSO, DMF, THF, DCM, Acetonitrile
- pka
- 11.95±0.46(Predicted)
- form
- Oil
- color
- Colorless to light yellow
- Appearance
- colorless syrup
TCO-PEG4-NHS Ester Usage And Synthesis
Description
TCO-PEG4-NHS ester is a bifunctional linker with trans-cyclooctene (TCO) and NHS ester groups flanking PEG4 (tetraethylene glycol).
The PEG spacer increases solubility in aqueous media and provides a long and flexible connection that minimizes steric hindrance involved with ligation.
The amine-reactive N-hydroxysuccinimide residue provides easy attachment to almost any primary or secondary amine group, such as protein, peptide, or small molecule amine.
Trans-cyclooctene readily reacts with tetrazines via inverse electron-demand Diels-Alder cycloaddition (IEDDA). TCO-Tetrazine ligation possesses ultrafast kinetics, selectivity, and long-term aqueous stability, which is important in low-concentration applications such as protein-protein conjugations, etc.
Uses
TCO-PEG4-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. TCO-PEG4-NHS ester is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
IC 50
PEGs
References
[1] Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-1013. DOI:10.1016/j.chembiol.2020.07.021
TCO-PEG4-NHS EsterSupplier
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 0519-85528066 13775048983
- sales@hopschem.com
- Tel
- 0371-037163312495,13303845143 13303845143
- 3001379618@qq.com
- Tel
- 13892832556
- 2440688701@qq.com
- Tel
- +86-13759708231
- asherw9@hotmail.com